{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T05:54:10Z","timestamp":1781762050980,"version":"3.54.5"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiol med"],"DOI":"10.1007\/s11547-026-02192-2","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T11:45:40Z","timestamp":1772538340000},"page":"893-914","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MRI features and LI-RADS categorization of combined hepatocellular-cholangiocarcinoma: a scoping review with prognostic implications"],"prefix":"10.1007","volume":"131","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-7805-0562","authenticated-orcid":false,"given":"Xu Jing","family":"Qian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6207-1843","authenticated-orcid":false,"given":"Ali","family":"Ramji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Samji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4959-8934","authenticated-orcid":false,"given":"Gavin","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1630-5138","authenticated-orcid":false,"given":"Mitchell P.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"key":"2192_CR1","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/hep.29789","volume":"68","author":"E Brunt","year":"2018","unstructured":"Brunt E, Aishima S, Clavien P-A et al (2018) cHCC-CCA: consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation. Hepatology 68:113\u2013126. https:\/\/doi.org\/10.1002\/hep.29789","journal-title":"Hepatology"},{"key":"2192_CR2","volume-title":"WHO classification of tumours of the digestive system","author":"WHO Classification of Tumours Editorial Board","year":"2019","unstructured":"WHO Classification of Tumours Editorial Board (2019) WHO classification of tumours of the digestive system, 5th ed. International Agency for Research on Cancer, Lyon","edition":"5th ed"},{"key":"2192_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.934045","volume":"12","author":"X Liu","year":"2022","unstructured":"Liu X, Ni X, Li Y, Yang C, Wang Y, Ma C, Zhou C, Lu X (2022) Diagnostic performance of LI-RADS version 2018 for primary liver cancer in patients with liver cirrhosis on enhanced MRI. Front Oncol 12:934045. https:\/\/doi.org\/10.3389\/fonc.2022.934045","journal-title":"Front Oncol"},{"key":"2192_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1159\/000530700","volume":"13","author":"L Ye","year":"2023","unstructured":"Ye L, Schneider JS, Ben Khaled N et al (2023) Combined hepatocellular-cholangiocarcinoma: biology, diagnosis, and management. Liver Cancer 13:6\u201328. https:\/\/doi.org\/10.1159\/000530700","journal-title":"Liver Cancer"},{"key":"2192_CR5","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1111\/j.1600-6143.2010.03062.x","volume":"10","author":"C Panjala","year":"2010","unstructured":"Panjala C, Senecal DL, Bridges MD, Kim GP, Nakhleh RE, Nguyen JHH, Harnois DM (2010) The diagnostic conundrum and liver transplantation outcome for combined hepatocellular-cholangiocarcinoma. Am J Transplant 10:1263\u20131267. https:\/\/doi.org\/10.1111\/j.1600-6143.2010.03062.x","journal-title":"Am J Transplant"},{"key":"2192_CR6","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1148\/radiol.2018181494","volume":"289","author":"V Chernyak","year":"2018","unstructured":"Chernyak V, Fowler KJ, Kamaya A et al (2018) Liver imaging reporting and data system (LI-RADS) version 2018: imaging of hepatocellular carcinoma in at-risk patients. Radiology 289:816\u2013830. https:\/\/doi.org\/10.1148\/radiol.2018181494","journal-title":"Radiology"},{"key":"2192_CR7","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2214\/AJR.12.9488","volume":"201","author":"KJ Fowler","year":"2013","unstructured":"Fowler KJ, Sheybani A, Parker RA, Doherty S, Brunt EM, Chapman WC, Menias CO (2013) Combined hepatocellular and cholangiocarcinoma (biphenotypic) tumors: imaging features and diagnostic accuracy of contrast-enhanced CT and MRI. AJR Am J Roentgenol 201:332\u2013339. https:\/\/doi.org\/10.2214\/AJR.12.9488","journal-title":"AJR Am J Roentgenol"},{"key":"2192_CR8","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W et al (2018) PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med 169:467\u2013473. https:\/\/doi.org\/10.7326\/M18-0850","journal-title":"Ann Intern Med"},{"key":"2192_CR9","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1007\/BF00206932","volume":"19","author":"T Hashimoto","year":"1994","unstructured":"Hashimoto T, Nakamura H, Hori S et al (1994) MR imaging of mixed hepatocellular and cholangiocellular carcinoma. Abdom Imaging 19:430\u2013432. https:\/\/doi.org\/10.1007\/BF00206932","journal-title":"Abdom Imaging"},{"key":"2192_CR10","doi-asserted-by":"publisher","first-page":"3940","DOI":"10.3748\/wjg.15.3940","volume":"15","author":"I Willekens","year":"2009","unstructured":"Willekens I, Hoorens A, Geers C, de Beeck BO, Vandenbroucke F, de Mey J (2009) Combined hepatocellular and cholangiocellular carcinoma presenting with radiological characteristics of focal nodular hyperplasia. World J Gastroenterol 15:3940\u20133943. https:\/\/doi.org\/10.3748\/wjg.15.3940","journal-title":"World J Gastroenterol"},{"key":"2192_CR11","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1002\/jmri.23754","volume":"36","author":"ROP de Campos","year":"2012","unstructured":"de Campos ROP, Semelka RC, Azevedo RM, Ramalho M, Heredia V, Armao DM, Woosley JT (2012) Combined hepatocellular carcinoma-cholangiocarcinoma: report of MR appearance in eleven patients. J Magn Reson Imaging 36:1139\u20131147. https:\/\/doi.org\/10.1002\/jmri.23754","journal-title":"J Magn Reson Imaging"},{"key":"2192_CR12","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1002\/jmri.23728","volume":"36","author":"J Hwang","year":"2012","unstructured":"Hwang J, Kim YK, Park MJ, Lee MH, Kim SH, Lee WJ, Rhim HC (2012) Differentiating combined hepatocellular and cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma using gadoxetic acid-enhanced MRI. J Magn Reson Imaging 36:881\u2013889. https:\/\/doi.org\/10.1002\/jmri.23728","journal-title":"J Magn Reson Imaging"},{"key":"2192_CR13","doi-asserted-by":"publisher","first-page":"416","DOI":"10.3350\/cmh.2012.18.4.416","volume":"18","author":"SJ Noh","year":"2012","unstructured":"Noh SJ, Lee HK, Yu HC, Moon WS (2012) Exophytic combined hepatocellular carcinoma and cholangiocarcinoma. Clin Mol Hepatol 18:416\u2013419. https:\/\/doi.org\/10.3350\/cmh.2012.18.4.416","journal-title":"Clin Mol Hepatol"},{"key":"2192_CR14","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1007\/s10620-013-2585-1","volume":"58","author":"S Singh","year":"2013","unstructured":"Singh S, Chakraborty S, Bonthu N, Radio S, Hussain SH, Sasson A (2013) Combined hepatocellular cholangiocarcinoma: a case report and review of literature. Dig Dis Sci 58:2114\u20132123. https:\/\/doi.org\/10.1007\/s10620-013-2585-1","journal-title":"Dig Dis Sci"},{"key":"2192_CR15","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jcv.2013.01.012","volume":"57","author":"K Uchino","year":"2013","unstructured":"Uchino K, Tateishi R, Nakagawa H et al (2013) Uninodular combined hepatocellular and cholangiocarcinoma with multiple non-neoplastic hypervascular lesions appearing in the liver of a patient with HIV and HCV coinfection. J Clin Virol 57:173\u2013177. https:\/\/doi.org\/10.1016\/j.jcv.2013.01.012","journal-title":"J Clin Virol"},{"key":"2192_CR16","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/s00261-013-0069-6","volume":"39","author":"AS Shetty","year":"2014","unstructured":"Shetty AS, Fowler KJ, Brunt EM, Agarwal S, Narra VR, Menias CO (2014) Combined hepatocellular-cholangiocarcinoma: what the radiologist needs to know about biphenotypic liver carcinoma. Abdom Imaging 39:310\u2013322. https:\/\/doi.org\/10.1007\/s00261-013-0069-6","journal-title":"Abdom Imaging"},{"key":"2192_CR17","doi-asserted-by":"publisher","first-page":"694","DOI":"10.3748\/wjg.v21.i2.694","volume":"21","author":"H-Q Gao","year":"2015","unstructured":"Gao H-Q, Yang Y-M, Zhuang Y, Liu P (2015) Locally advanced undifferentiated carcinoma with osteoclast-like giant cells of the pancreas. World J Gastroenterol 21:694\u2013698. https:\/\/doi.org\/10.3748\/wjg.v21.i2.694","journal-title":"World J Gastroenterol"},{"key":"2192_CR18","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.clinimag.2015.06.013","volume":"39","author":"E Quaia","year":"2015","unstructured":"Quaia E, Angileri R, Arban F, Gennari AG, Cova MA (2015) Predictors of intrahepatic cholangiocarcinoma in cirrhotic patients scanned by gadobenate dimeglumine-enhanced magnetic resonance imaging: diagnostic accuracy and confidence. Clin Imaging 39:1032\u20131038. https:\/\/doi.org\/10.1016\/j.clinimag.2015.06.013","journal-title":"Clin Imaging"},{"key":"2192_CR19","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1007\/s00261-016-0811-y","volume":"41","author":"RF Sheng","year":"2016","unstructured":"Sheng RF, Xie YH, Ji Y, Chen CZ, Yang L, Jin KP, Zeng MS (2016) MR comparative study of combined hepatocellular-cholangiocarcinoma in normal, fibrotic, and cirrhotic livers. Abdom Radiol (NY) 41:2102\u20132114. https:\/\/doi.org\/10.1007\/s00261-016-0811-y","journal-title":"Abdom Radiol (NY)"},{"key":"2192_CR20","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/jmri.25568","volume":"46","author":"SH Park","year":"2017","unstructured":"Park SH, Lee SS, Yu E et al (2017) Combined hepatocellular-cholangiocarcinoma: Gadoxetic acid-enhanced MRI findings correlated with pathologic features and prognosis. J Magn Reson Imaging 46:267\u2013280. https:\/\/doi.org\/10.1002\/jmri.25568","journal-title":"J Magn Reson Imaging"},{"key":"2192_CR21","doi-asserted-by":"publisher","first-page":"77","DOI":"10.4993\/acrt.25.77","volume":"25","author":"S Tsuda","year":"2017","unstructured":"Tsuda S, Maeda H, Uemura S et al (2017) Sarcomatoid combined hepatocellular carcinoma and cholangiocarcinoma of liver with spontaneous intra-tumor bleeding: a case report. ACRT 25:77\u201380. https:\/\/doi.org\/10.4993\/acrt.25.77","journal-title":"ACRT"},{"key":"2192_CR22","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1007\/s00261-018-1638-5","volume":"43","author":"E Ehman","year":"2018","unstructured":"Ehman E, Garg I, Fidler JL, Wells ML, Takahashi N, Goenka A, Carter RE, Venkatesh SK (2018) MRI to distinguish between heaptocellular carcinoma, intrahepatic cholangiocarcinoma, and biphenotypic tumors. Abdom Radiol 43:1853\u20131884. https:\/\/doi.org\/10.1007\/s00261-018-1638-5","journal-title":"Abdom Radiol"},{"key":"2192_CR23","doi-asserted-by":"publisher","first-page":"870","DOI":"10.3748\/wjg.v24.i7.870","volume":"24","author":"M Salimon","year":"2018","unstructured":"Salimon M, Chapelle N, Matysiak-Budnik T, Mosnier J, Frampas E, Touchefeu Y (2018) Esophageal metastasis of stem cell-subtype hepatocholangiocarcinoma: rare presentation of a rare tumor. World J Gastroenterol 24:870\u2013875. https:\/\/doi.org\/10.3748\/wjg.v24.i7.870","journal-title":"World J Gastroenterol"},{"key":"2192_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s40644-018-0142-z","volume":"18","author":"J Sammon","year":"2018","unstructured":"Sammon J, Fischer S, Menezes R, Hosseini-Nik H, Lewis S, Taouli B, Jhaveri K (2018) MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma. Cancer Imaging 18:8. https:\/\/doi.org\/10.1186\/s40644-018-0142-z","journal-title":"Cancer Imaging"},{"key":"2192_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4969-2","volume":"18","author":"Z-G Zhang","year":"2018","unstructured":"Zhang Z-G, Chen Y, Ji R, Zhao Y-J, Wang J, Robinson L, Chen X-P, Zhang L (2018) Synchronous cancers of gallbladder carcinoma and combined hepatocellular cholangiocarcinoma: an unusual case and literature review. BMC Cancer 18:1046. https:\/\/doi.org\/10.1186\/s12885-018-4969-2","journal-title":"BMC Cancer"},{"key":"2192_CR26","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/3418950","volume":"2019","author":"RML Colunga Biancatelli","year":"2019","unstructured":"Colunga Biancatelli RML, Ciacciarelli M, Polidoro A et al (2019) Combined hepatocholangiocarcinoma associated with humoral hypercalcemia of malignancy and chronic inflammatory demyelinating polyneuropathy. Case Rep Oncol Med 2019:3418950. https:\/\/doi.org\/10.1155\/2019\/3418950","journal-title":"Case Rep Oncol Med"},{"key":"2192_CR27","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1148\/radiol.2018181290","volume":"290","author":"SH Choi","year":"2019","unstructured":"Choi SH, Lee SS, Park SH, Kim KM, Yu E, Park Y, Shin YM, Lee M-G (2019) LI-RADS classification and prognosis of primary liver cancers at gadoxetic acid\u2013enhanced MRI. Radiology 290:388\u2013397. https:\/\/doi.org\/10.1148\/radiol.2018181290","journal-title":"Radiology"},{"key":"2192_CR28","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s00330-018-5605-x","volume":"29","author":"SK Jeon","year":"2019","unstructured":"Jeon SK, Joo I, Lee DH, Lee SM, Kang H-J, Lee K-B, Lee JM (2019) Combined hepatocellular cholangiocarcinoma: LI-RADS v2017 categorisation for differential diagnosis and prognostication on gadoxetic acid-enhanced MR imaging. Eur Radiol 29:373\u2013382. https:\/\/doi.org\/10.1007\/s00330-018-5605-x","journal-title":"Eur Radiol"},{"key":"2192_CR29","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1007\/s00330-018-5893-1","volume":"29","author":"HS Lee","year":"2019","unstructured":"Lee HS, Kim M-J, An C (2019) How to utilize LR-M features of the LI-RADS to improve the diagnosis of combined hepatocellular-cholangiocarcinoma on gadoxetate-enhanced MRI? Eur Radiol 29:2408\u20132416. https:\/\/doi.org\/10.1007\/s00330-018-5893-1","journal-title":"Eur Radiol"},{"key":"2192_CR30","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1177\/2050640618815378","volume":"7","author":"E Sagrini","year":"2019","unstructured":"Sagrini E, Iavarone M, Stefanini F et al (2019) Imaging of combined hepatocellular-cholangiocarcinoma in cirrhosis and risk of false diagnosis of hepatocellular carcinoma. United Eur Gastroenterol J 7:69\u201377. https:\/\/doi.org\/10.1177\/2050640618815378","journal-title":"United Eur Gastroenterol J"},{"key":"2192_CR31","doi-asserted-by":"publisher","first-page":"3743","DOI":"10.1007\/s00261-020-02562-y","volume":"45","author":"S-S Kim","year":"2020","unstructured":"Kim S-S, Lee S, Choi J-Y, Lim JS, Park M-S, Kim M-J (2020) Diagnostic performance of the LR-M criteria and spectrum of LI-RADS imaging features among primary hepatic carcinomas. Abdom Radiol 45:3743\u20133754. https:\/\/doi.org\/10.1007\/s00261-020-02562-y","journal-title":"Abdom Radiol"},{"key":"2192_CR32","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1007\/s00261-020-02421-w","volume":"45","author":"K Lim","year":"2020","unstructured":"Lim K, Kwon H, Cho J (2020) Inter-reader agreement and imaging-pathology correlation of the LI-RADS M on gadoxetic acid-enhanced magnetic resonance imaging: efforts to improve diagnostic performance. Abdom Radiol 45:2430\u20132439. https:\/\/doi.org\/10.1007\/s00261-020-02421-w","journal-title":"Abdom Radiol"},{"issue":"3","key":"2192_CR33","first-page":"1058","volume":"20","author":"M Najjar","year":"2020","unstructured":"Najjar M, Makkar J, Sun S et al (2020) Imaging Features and Diagnostic Accuracy of MRI in Combined Hepatocholangiocarcinoma. Am J Transplant 20(3):1058","journal-title":"Am J Transplant"},{"key":"2192_CR34","doi-asserted-by":"publisher","DOI":"10.17305\/bjbms.2019.4576","author":"S Shao","year":"2020","unstructured":"Shao S, Liang Y, Kuang S et al (2020) Diagnostic performance of LI-RADS version 2018 in differentiating hepatocellular carcinoma from other hepatic malignancies in patients with hepatitis B virus infection. Biomol Biomed. https:\/\/doi.org\/10.17305\/bjbms.2019.4576","journal-title":"Biomol Biomed"},{"key":"2192_CR35","doi-asserted-by":"publisher","first-page":"5337","DOI":"10.1007\/s00330-020-06861-2","volume":"30","author":"X Wang","year":"2020","unstructured":"Wang X, Wang W, Ma X, Lu X, Li S, Zeng M, Xu K, Yang C (2020) Combined hepatocellular-cholangiocarcinoma: which preoperative clinical data and conventional MRI characteristics have value for the prediction of microvascular invasion and clinical significance? Eur Radiol 30:5337\u20135347. https:\/\/doi.org\/10.1007\/s00330-020-06861-2","journal-title":"Eur Radiol"},{"key":"2192_CR36","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1002\/jmri.27528","volume":"53","author":"DH Kim","year":"2021","unstructured":"Kim DH, Choi SH, Kim DW et al (2021) Combined hepatocellular-cholangiocarcinoma: magnetic resonance imaging features and prognosis according to risk factors for hepatocellular carcinoma. J Magn Reson Imaging 53:1803\u20131812. https:\/\/doi.org\/10.1002\/jmri.27528","journal-title":"J Magn Reson Imaging"},{"key":"2192_CR37","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1111\/liv.14798","volume":"41","author":"J Yoon","year":"2021","unstructured":"Yoon J, Hwang JA, Lee S, Lee JE, Ha SY, Park YN (2021) Clinicopathologic and MRI features of combined hepatocellular-cholangiocarcinoma in patients with or without cirrhosis. Liver Int 41:1641\u20131651. https:\/\/doi.org\/10.1111\/liv.14798","journal-title":"Liver Int"},{"key":"2192_CR38","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.mpdhp.2021.11.006","volume":"28","author":"SH Lee","year":"2022","unstructured":"Lee SH, Luong TV (2022) Combined hepatocellular-cholangiocarcinoma: a rare biphenotypic primary liver cancer. Diagn Histopathol 28:116\u2013118. https:\/\/doi.org\/10.1016\/j.mpdhp.2021.11.006","journal-title":"Diagn Histopathol"},{"key":"2192_CR39","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/4691172","volume":"2022","author":"L Lu","year":"2022","unstructured":"Lu L, Zhang C, Yu X et al (2022) The value of contrast-enhanced magnetic resonance imaging enhancement in the differential diagnosis of hepatocellular carcinoma and combined hepatocellular cholangiocarinoma. J Oncol 2022:4691172. https:\/\/doi.org\/10.1155\/2022\/4691172","journal-title":"J Oncol"},{"key":"2192_CR40","doi-asserted-by":"publisher","first-page":"5004","DOI":"10.1007\/s00330-022-08548-2","volume":"32","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Zhou G, Zhang J, Xu C, Zhu F, Xu P (2022) DCE-MRI based radiomics nomogram for preoperatively differentiating combined hepatocellular-cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma. Eur Radiol 32:5004\u20135015. https:\/\/doi.org\/10.1007\/s00330-022-08548-2","journal-title":"Eur Radiol"},{"key":"2192_CR41","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1007\/s11547-023-01682-x","volume":"128","author":"R Sheng","year":"2023","unstructured":"Sheng R, Yang C, Zhang Y, Wang H, Zheng B, Han J, Sun W, Zeng M (2023) The significance of the predominant component in combined hepatocellular-cholangiocarcinoma: MRI manifestation and prognostic value. Radiol Med 128:1047\u20131060. https:\/\/doi.org\/10.1007\/s11547-023-01682-x","journal-title":"Radiol Med"},{"key":"2192_CR42","doi-asserted-by":"publisher","first-page":"e817","DOI":"10.1016\/j.crad.2024.02.001","volume":"79","author":"X Deng","year":"2024","unstructured":"Deng X, Liao Z (2024) A machine-learning model based on dynamic contrast-enhanced MRI for preoperative differentiation between hepatocellular carcinoma and combined hepatocellular-cholangiocarcinoma. Clin Radiol 79:e817\u2013e825. https:\/\/doi.org\/10.1016\/j.crad.2024.02.001","journal-title":"Clin Radiol"},{"key":"2192_CR43","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s00261-023-04174-8","volume":"49","author":"Y Xiao","year":"2024","unstructured":"Xiao Y, Huang P, Zhang Y et al (2024) Component prediction in combined hepatocellular carcinoma-cholangiocarcinoma: habitat imaging and its biologic underpinnings. Abdom Radiol 49:1063\u20131073. https:\/\/doi.org\/10.1007\/s00261-023-04174-8","journal-title":"Abdom Radiol"},{"key":"2192_CR44","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s13244-024-01741-5","volume":"15","author":"Y Xiao","year":"2024","unstructured":"Xiao Y, Wu F, Hou K, Wang F, Zhou C, Huang P, Yang C, Zeng M (2024) MR radiomics to predict microvascular invasion status and biological process in combined hepatocellular carcinoma-cholangiocarcinoma. Insights Imaging 15:172. https:\/\/doi.org\/10.1186\/s13244-024-01741-5","journal-title":"Insights Imaging"},{"key":"2192_CR45","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1007\/s00261-023-04130-6","volume":"49","author":"J Zhang","year":"2024","unstructured":"Zhang J, Dong W, Liu W, Fu J, Liao T, Li Y, Huo L, Jia N (2024) Preoperative evaluation of MRI features and inflammatory biomarkers in predicting microvascular invasion of combined hepatocellular cholangiocarcinoma. Abdom Radiol 49:710\u2013721. https:\/\/doi.org\/10.1007\/s00261-023-04130-6","journal-title":"Abdom Radiol"},{"key":"2192_CR46","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1007\/s00261-024-04194-y","volume":"49","author":"C Zhou","year":"2024","unstructured":"Zhou C, Huang P, Wu F, Xiao Y, Yang C, Zeng M (2024) How to differentiate between combined hepatocellular carcinoma-cholangiocarcinoma and intrahepatic cholangiocarcinoma with rim arterial phase hyperenhancement? Abdom Radiol 49:3015\u20133023. https:\/\/doi.org\/10.1007\/s00261-024-04194-y","journal-title":"Abdom Radiol"},{"key":"2192_CR47","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1002\/cncr.10392","volume":"94","author":"WR Jarnagin","year":"2002","unstructured":"Jarnagin WR, Weber S, Tickoo SK et al (2002) Combined hepatocellular and cholangiocarcinoma. Cancer 94:2040\u20132046. https:\/\/doi.org\/10.1002\/cncr.10392","journal-title":"Cancer"},{"key":"2192_CR48","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1007\/s00261-015-0433-9","volume":"40","author":"ML Wells","year":"2015","unstructured":"Wells ML, Venkatesh SK, Chandan VS, Fidler JL, Fletcher JG, Johnson GB, Hough DM, Roberts LR (2015) Biphenotypic hepatic tumors: imaging findings and review of literature. Abdom Imaging 40:2293\u20132305. https:\/\/doi.org\/10.1007\/s00261-015-0433-9","journal-title":"Abdom Imaging"},{"key":"2192_CR49","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/cld.1047","volume":"17","author":"M Krishna","year":"2021","unstructured":"Krishna M (2021) Pathology of cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma. Clin Liver Dis 17:255\u2013260. https:\/\/doi.org\/10.1002\/cld.1047","journal-title":"Clin Liver Dis"},{"key":"2192_CR50","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/lt.23897","volume":"20","author":"M Garancini","year":"2014","unstructured":"Garancini M, Goffredo P, Pagni F, Romano F, Roman S, Sosa JA, Giardini V (2014) Combined hepatocellular-cholangiocarcinoma: a population-level analysis of an uncommon primary liver tumor. Liver Transpl 20:952\u2013959. https:\/\/doi.org\/10.1002\/lt.23897","journal-title":"Liver Transpl"},{"key":"2192_CR51","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.14094","volume":"35","author":"D Jaradat","year":"2021","unstructured":"Jaradat D, Bagias G, Lorf T, Tokat Y, Obed A, Oezcelik A (2021) Liver transplantation for combined hepatocellular-cholangiocarcinoma: Outcomes and prognostic factors for mortality A multicenter analysis. Clin Transplant 35:e14094. https:\/\/doi.org\/10.1111\/ctr.14094","journal-title":"Clin Transplant"},{"key":"2192_CR52","doi-asserted-by":"publisher","first-page":"300","DOI":"10.4254\/wjh.v9.i6.300","volume":"9","author":"S Gera","year":"2017","unstructured":"Gera S, Ettel M, Acosta-Gonzalez G, Xu R (2017) Clinical features, histology, and histogenesis of combined hepatocellular-cholangiocarcinoma. World J Hepatol 9:300\u2013309. https:\/\/doi.org\/10.4254\/wjh.v9.i6.300","journal-title":"World J Hepatol"},{"key":"2192_CR53","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2214\/AJR.15.14997","volume":"207","author":"TA Potretzke","year":"2016","unstructured":"Potretzke TA, Tan BR, Doyle MB, Brunt EM, Heiken JP, Fowler KJ (2016) Imaging features of biphenotypic primary liver carcinoma (hepatocholangiocarcinoma) and the potential to mimic hepatocellular carcinoma: LI-RADS analysis of CT and MRI features in 61 cases. AJR Am J Roentgenol 207:25\u201331. https:\/\/doi.org\/10.2214\/AJR.15.14997","journal-title":"AJR Am J Roentgenol"},{"key":"2192_CR54","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1007\/s00595-006-3276-8","volume":"36","author":"W-S Lee","year":"2006","unstructured":"Lee W-S, Lee K-W, Heo J-S, Kim S-J, Choi S-H, Kim Y-I, Joh J-W (2006) Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Surg Today 36:892\u2013897. https:\/\/doi.org\/10.1007\/s00595-006-3276-8","journal-title":"Surg Today"},{"key":"2192_CR55","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s00330-020-07119-7","volume":"31","author":"X Liu","year":"2021","unstructured":"Liu X, Khalvati F, Namdar K, Fischer S, Lewis S, Taouli B, Haider MA, Jhaveri KS (2021) Can machine learning radiomics provide pre-operative differentiation of combined hepatocellular cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma to inform optimal treatment planning? Eur Radiol 31:244\u2013255. https:\/\/doi.org\/10.1007\/s00330-020-07119-7","journal-title":"Eur Radiol"},{"key":"2192_CR56","doi-asserted-by":"publisher","first-page":"795","DOI":"10.2147\/JHC.S406648","volume":"10","author":"L Guo","year":"2023","unstructured":"Guo L, Li X, Zhang C, Xu Y, Han L, Zhang L (2023) Radiomics based on dynamic contrast-enhanced magnetic resonance imaging in preoperative differentiation of combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma: a multi-center study. J Hepatocell Carcinoma 10:795\u2013806. https:\/\/doi.org\/10.2147\/JHC.S406648","journal-title":"J Hepatocell Carcinoma"}],"container-title":["La radiologia medica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-026-02192-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11547-026-02192-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-026-02192-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T05:19:45Z","timestamp":1781759985000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11547-026-02192-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":56,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["2192"],"URL":"https:\/\/doi.org\/10.1007\/s11547-026-02192-2","relation":{},"ISSN":["1826-6983"],"issn-type":[{"value":"1826-6983","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]},"assertion":[{"value":"15 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study is exempt from ethical approval at our institution because the analysis involves only de-identified data from previously published material.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}